Gene · 409
Papers2,219
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,219
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic targeting of Aurora Kinase A in advanced prostate cancer. | Serican J Med | 2025 | 41658018 | PubTator, text mining | PubMed |
| Identifying the biomarkers associated with G protein-coupled receptors of parkinson's disease. | Sci Rep | 2025 | 41390872 | PubTator, text mining | PubMed |
| A novel long-galanin peptide from non-mammalian vertebrates mitigates the inflammatory response in IBD models via the biased GALR2/β-arrestin2 pathway. | Nat Commun | 2025 | 41390752 | PubTator, text mining | PubMed |
| Negative Allosteric Modulation of Agonist-Induced M2 Muscarinic Receptor/β-Arrestin Interaction by Serum Autoantibodies from Patients with Chronic Chagas Disease. | Cells | 2025 | 41369345 | PubTator, text mining | PubMed |
| Identification of oxidative stress-responsive genes in recurrent miscarriage and their role in disease pathogenesis. | PLoS One | 2025 | 41329780 | PubTator, text mining | PubMed |
| Activated protein C promotes β-arrestin-2- and c-Src-dependent caveolin-1 (Cav1) phosphorylation and alters Cav1 association with PAR1 and GRK5. | bioRxiv | 2025 | 41279694 | PubTator, text mining | PubMed |
| Construction of Five Epithelial Immune-Related Gene Signatures and Verification of OPRK1 as a Prognostic Biomarker for Prostate Cancer. | Arch Esp Urol | 2025 | 41111380 | PubTator, text mining | PubMed |
| Mechanistic Basis for GPCR Phosphorylation-Dependent Allosteric Signaling Specificity of β-Arrestin 1 and 2. | J Chem Inf Model | 2025 | 41082500 | PubTator, text mining | PubMed |
| Stabilized D2R G protein-coupled receptor oligomers identify multi-state β-arrestin complexes. | Nat Commun | 2025 | 41038823 | PubTator, text mining | PubMed |
| The m6A modification in cancer: roles, implications, and its potential in therapy. | Mol Biomed | 2025 | 40986143 | PubTator, text mining | PubMed |
| A Preliminary Prospective Study on the Association of Polymorphisms in BDNF, ARRB2 and KCNJ6 and Response to Fentanyl for Pain Management in Advanced Cancer. | Cancer Control | 2025 | 40973140 | PubTator, text mining | PubMed |
| Harnessing natural killer cell-related genes for prognostic and therapeutic advances in lung adenocarcinoma: a predictive model for survival and immunotherapy outcomes. | Transl Cancer Res | 2025 | 40950687 | PubTator, text mining | PubMed |
| REG3A promotes gemcitabine resistance in pancreatic cancer via the GPR54/ARRB2/ERK1/2 ligand-directed signaling pathway. | Biochem Pharmacol | 2025 | 40935160 | PubTator, text mining | PubMed |
| Major pathophysiological changes in pulmonary disease provided a molecular insight based on deep learning approach. | Sci Rep | 2025 | 40887476 | PubTator, text mining | PubMed |
| Decoding ADGRE5: How Proteolytic Cleavage and Mechanical Forces Unleash Cellular Signals. | Cells | 2025 | 40862763 | PubTator, text mining | PubMed |
| Cannabidiol and Alzheimer Disease: A Comprehensive Review and In Silico Insights Into Molecular Interactions. | Eur J Neurosci | 2025 | 40859865 | PubTator, text mining | PubMed |
| Pain management beyond opioids: a β-arrestin2-biased allosteric GPCR modulator opens new avenues for drug development. | Signal Transduct Target Ther | 2025 | 40858534 | PubTator, text mining | PubMed |
| Identification of foam cell like M2 macrophages, AEBP1 biomarkers, and resveratrol as potential therapeutic in MASLD using Ecotyper and WGCNA. | Sci Rep | 2025 | 40825823 | PubTator, text mining | PubMed |
| Molecular mechanism of β-arrestin 2 interaction with phosphorylated intracellular loop 3 of dopamine receptor D2. | Commun Biol | 2025 | 40781549 | PubTator, text mining | PubMed |
| An arginine switch drives the stepwise activation of β-arrestin by CXCR7. | PLoS Biol | 2025 | 40773476 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/409/papers?page=2